CD44 as a tumor biomarker and therapeutic target

Overview of attention for article published in Experimental Hematology & Oncology, December 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,088 followers.

RT @cancerscnews: 📚 In this review, Dr. Aiguo Liu's team discuss the current data relevant to CD44, its structure and functional properties…

RT @cancerscnews: 📚 In this review, Dr. Aiguo Liu's team discuss the current data relevant to CD44, its structure and functional properties…

RT @cancerscnews: 📚 In this review, Dr. Aiguo Liu's team discuss the current data relevant to CD44, its structure and functional properties…

📚 In this review, Dr. Aiguo Liu's team discuss the current data relevant to CD44, its structure and functional properties, and its role in #carcinogenesis and cancer progression. 📂 https://t.co/tZ55T5HjLs https://t.co/rhewhxodMe

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.